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Cultivated mushrooms are not only valuable foods of our age (functional foods) but contain certain benefi cial 
chemical components (high level of K and P, very low content of Na, considerable quantities of some microelements, 
high and valuable protein but low fat contents). Some cultivated mushrooms have anti-carcinogenic effects caused 
fi rst of all by polysaccharides (Lentinan: Lentinula edodes) and by triterpenoids (ganoderic acids: Ganoderma 
lucidum or unsaturated fatty acids: linoleic, linolenic acids); antidiabetic effects, which can improve the sugar 
metabolism of patients (Coprinus comatus, Ganoderma lucidum, Agaricus bisporus); anti-microbial effects, caused 
partly by smaller triterpenoids or by higher molecules, i.e. by direct or indirect effects: via stimulation of the immune 
system. Certain mushrooms have antioxidant effects, provided mostly by higher radical scavenging activity of 
phenolic (fl avonoid) components. The chemical composition and its biological effects form together the biological 
values of the cultivated mushrooms.
The following review would like to summarize the most important facts of this topic.
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Mushrooms have been consumed since earliest historical times; Greeks believed that 
mushrooms provided strength for warriors, the Romans named them as the “Food of the 
Gods”. In countries of the Orient, certain mushrooms were believed “elixir of life” etc. 
Mushrooms were used and valued as culinary delicacies and as medicines by the Greek, 
Egyptian, Roman, Chinese and Mexican civilizations.
Mushrooms were interpreted earlier as a specifi c (modifi ed) group of plant kingdom; 
today they are fungi belonging to Regnum Fungorum; these species have macroscopic 
fruiting bodies (carpophores) and may be ranked to Ascomycota and mainly to Basidiomycota 
phylums.
1. Cultivated mushrooms as functional foods
The term “functional food” was used fi rst in Japan in the 1980s. In 1996 a European Consensus 
on “Scientifi c Concepts of Functional Food” was developed, which was published in 1999 
(ROBERFROID, 2002). The main aspects of this scientifi c defi nition are:
1. The functional food affects positively one or more functions of the body beyond 
adequate nutritional effects;
2. Its effect can be the improving of health and well-being (fi tness) or reduction of risk 
of disease; it is not a capsule or tablet, but part of the normal food pattern.
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2. Composition and nutritional values of cultivated mushrooms
Use of fungi as foods is in vogue since ancient times, archaeological evidences documented 
it for the inhabitants of Chile almost 13 000 years ago (GHORAI et al., 2009).
Exact historical data may document the beginning of the mushroom growing for France 
(in XVII–XVIII centuries). The modern mushroom growing or industry has shown a 
spectacular expansion in the last decades: over a 15-year period (1997 to 2012) consumption 
of mushrooms per capita increased drastically from about 1 kg/year to over 4 kg/year (ROYSE, 
2014).
2.1. Inorganic components
Water is an essential component of all living things including the mushrooms. Interpretability 
of osmotic relations, nutrition, transpiration, growth, and development as main life processes 
is impossible without water. The water content of fruiting bodies is high (average is about 
90%), exception is for example the hard, dry fruiting body of Ganoderma lucidum. Contents 
of most important macro- and microelements are summarized in Table 1 based on data from 
scientifi c literature including earlier publications of our own.
Table 1. Mineral components in the most frequently cultivated mushrooms 
(in mg kg–1 DM, 1: pileus /cap/; 2: stipe; 3: whole fruiting bodies)
Mushroom species K P Mg Ca Na Cu Zn Mn
Agaricus bisporus 1
2
39 000
37 182
12 150
  9 120
1 410
1 088
1 388
1 818
699
942
39.5
29.2
64.7
55.7
8.31
6.47
Agaricus subrufescens 1
2
30 700
28 400
11 770
  6 790
1 160
   990
   958
1 520
140
188
151
73
254
144
8.8
6.1
Pleurotus ostreatus 1
2
30 700
21 386
  6 980
  2 950
1 369
   933
   820
   853
269
265
18.7
20.2
76.6
36.5
9.6
6.23
Pleurotus eryngii 1
2
22 303
16 659
  9 961
  6 562
1 530
1 264
   882
1 008
792
721
11.5
8.9
68.2
40.2
9.9
5.3
Lentinula edodes 1
2
23 200
11 840
  7 412
  3 772
1 341
1 420
1 148
1 330
439
454
13.2
8.1
82.2
49.9
21.4
16.9
Agrocybe cylindracea 1
2
24 500
37 500
13 800
13 200
1 570
1 640
     60
   120
  60
  90
30
30
80
80
10
10
Flammulina velutipes 3 28 000 n. d. 1 108    324 188 2.7 27 7.0
Volvariella volvacea 3 13 240 16 990    570 4 460 2 580 160 680 52
Auricularia auricula 3 4–5000   1 480    500 1800-
5000
104 9 38 n. d.
Coprinus cinereus 3 32 320 11 420    360 2 140 3 380 230 141 140
(Based on publications of GYÖRFI and co-workers, 2010; VETTER, 2010; KALAC, 2012; KRÜZSELYI and co-workers, 
2016); n. d.: no data
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Potassium is the main and fi rst mineral component in all mushrooms including wild-
growing species, too. Level of K in caps is signifi cantly higher than in stipes, but the rate of 
Kcap to Kstipe is different: in Agaricus bisporus it is about only 1.05, whereas for Lentinula 
edodes this rate is 1.88 (22.3 g kg–1 DM /=dry matter/ for cap and 11.8 g kg–1 DM for stipe). 
The highest potassium levels are found in Agaricus spp., followed by Pleurotus spp. Proper 
K-care is an essential element of our up-to-date, healthy nutrition, so the K-content of a food 
is also a factor of medical signifi cance.
Biological importance of phosphorus containing molecules is beyond doubt. P-content 
of cultivated mushrooms (Table 1) is remarkable, but the variability of these data is 
signifi cantly high; nutrition type of mushrooms can infl uence the actual P content: wood 
decaying mushrooms (Pleurotus species or Lentinula edodes) have lower P-levels.
Magnesium and calcium are classifi ed to the macroelements, their contents vary between 
500–1500 mg kg–1 DM; quantities of these two elements are mostly around identical or Mg-
level is higher than Ca-quantity (exceptions: Volvariella volvacea and Coprinus sp.).
Sodium contents vary between 100 and some hundred mg kg–1 DM (Table 1). Let’s take 
a short calculation: 1 kg dry mushroom contains for example 300 mg Na; ingestion of 100 g 
fresh mushroom means the uptake of 3 mg Na only, which is a negligible quantity (compared 
to other food types). Consumption of mushroom means the uptake of signifi cant potassium 
quantity (ingestion of 100 g fresh mushroom means about 300 mg K, the rate of K to Na is: 
100:1). This rate (which differs absolutely from other food types) seems to be a very essential 
biological value for consumers.
Data presented in Table 1 have contents of three important microelements, namely Cu, 
Zn, and Mn; the general situation for their contents: Zn>Cu>Mn.
The process of bioaccumulation is described for mushrooms, meaning a specifi c, 
extreme uptake and/or storage of certain mineral elements (VETTER, 1994, 1996; KALAC & 
SVOBODA, 2000; KALAC, 2016). Cu bioaccumulation is described for example for Macrolepiota 
species, extreme vanadium (V) accumulation characterizes the species Amanita muscaria, or 
arsenic (As) accumulation can be measured in fruiting bodies of Laccaria amethysthea or 
Sarcosphaera coronaria. Such processes are caused by synthesis and function of specifi c, 
“binding” organic molecules, which can absorb high (or extreme) quantities of the given 
element (As, Cu, V, and others). Accumulation of Se is characteristic mainly of wild growing 
Boletus spp. (25–40 mg kg–1 DM) or of species Albatrellus pres-caprae (VETTER & LELLEY, 
2004), while Se content of other species is usually not more than 0.1–0.2 mg kg–1 DM. 
Fruiting bodies of Pleurotus ostreatus, P. eryngii, or Lentinula edodes contain relatively low 
Se quantities, but different varieties of Agaricus bisporus have mostly 3–5 mg kg–1 DM 
contents (VETTER & LELLEY, 2004).
2.2. Organic constituents
Main organic constituents of cultivated mushrooms are given in Table 2 (in % of DM) based 
on different literature sources.
Published data of crude protein contents (N-content ×4.38) show great variability, the 
highest values characterize the Agaricus species: up to 36% for A. bisporus, up to 39% for A. 
subrufescens, and lower contents can be measured in wood decaying species (Lentinula 
edodes: 11–20%; Pleurotus ostreatus: 12–21%; Flammulina velutipes: 15–26%), see SALES-
CAMPOS and co-workers, (2011) and KALAC, (2016).
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Table 2. Nutritional values of the most frequently cultivated mushroom species
Mushroom species Crude protein
(% DM)
Crude fat
(% DM)
Carbohydrate
(% DM)
Energy 
(kcal/100 g DM)
Agaricus bisporus 14.0–36.3 0.8–2.5 50.9–74.0 303–325
Agaricus subrufescens 26.2–39.3 0.9–4.0 39–64.0 340–360
Pleurotus ostreatus 7.0–23.8 0.5–5.4 51.9–85 416
Pleurotus eryngii 11.0–22.0 1.45–1.57 70.5–81.4 421
Lentinula edodes 4.4–20.5 1.7–6.3 67.9–87.0 386
Agrocybe cylindracea 16.5–22.2 3.5–3.6 n. d. 130–179
Flammulina velutipes 3.9–26.6 2.9–9.23 56.6–85.9 467
Volvariella volvacea 36.5 2.2 52.3 n. d.
Auricularia auricula 5.7–15.5 0.4–4.5 77–91 97–140
Coprinus comatus 10.9 1.98 76.5 368
Ganoderma lucidum sensu lato 13.3 3.0 82.3 n. d.
(ULZIIJARGAL & MAU, 2011; HUNG & NHI, 2012; KALAC 2012; PARDO-GIMENEZ and co-workers, 2013); n. d.: no data
Formerly we compared (VETTER & RIMÓCZI, 1993) the protein levels in caps and stipe of 
P. ostreatus in different phases of maturation (according to the average diameter of caps: <5 
cm; 5–8 cm; 8–10 cm; >10 cm). The protein content of caps was highest in the second phase 
(25.4% DM), before and after this phase the crude protein levels were lower.
Qualifi cation of mushroom proteins is possible for example by contents and rates of 
essential amino acids, or by occurrence and rate of sulphur containing amino acids. 
Distributions of essential amino acids range between 32.9 and 48.9% of total amino acid 
content, 32.9% for A. bisporus varieties, 41–44% for Pleurotus species, and 41–44% for 
Lentinula edodes (VETTER, 2010). The relative occurrence of sulphur containing amino acids 
fl uctuates between 1.4 and 4.5% (lower data characterize the Agaricus and Pleurotus species).
Other aspect of protein qualifi cation is the evaluation based on solubility according to 
the “classical” fractionation by Osborne (albumins, globulins, prolamins, and glutelins). The 
solubility (or its absence) has a great biological role in uptake, digestion, and absorption of 
proteins, yet very limited data are available for mushrooms (BAUER-PETROWSKA, 2001). Our 
recent investigations (KRÜZSELYI et al., 2016) provide new facts. Percentage distribution of 
albumins (or albumins + globulins) is very high and benefi cial (about 80% of total true 
proteins for P. eryngii and about 60% for P. ostreatus).
Biological quality of fungal proteins is affected by different species and strains, growing 
methods, composition of substrates, age and development of fruit body (VETTER & RIMÓCZI, 
1993; DEL TORO et al., 2006, CHEUNG, 2008).
Crude (total) fat content of mushrooms is in general low (0.5–3% for DM). The actual 
fat content of 100 g fresh fruit body is about practically only one tenth (0.05–0.3%) of these 
values. A logical consequence of this low fat content is the low energy level of the mushrooms 
(see later). The rate of polyunsaturated fatty acids in mushrooms including cultivated ones is 
high, about 75% of total fatty acids. Most frequent components are linoleic (68–84%), 
palmitic (19.2%), and oleic acids (8.3%) (CHEUNG, 2008). Cultivated mushrooms contain 
high amounts of sterols (MATTILA et al., 2001), mainly ergosterol. Ergosterol contents of 
cultivated mushrooms were 780 mg/100 g DM for A. bisporus, 605 for L. edodes, 440 for P. 
ostreatus and for P. abalone, and only 68 for Flammulina velutipes (JASINGHE et al., 2005).
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Carbohydrates
Total carbohydrate content (calculated for DM) of the mushrooms is high, but it varies. 
This fraction contains monosaccharides, mainly as free sugars (glucose, fructose, mannose, 
arabinose, etc.) or sugar alcohols (mainly mannitol). Oligosaccharides (as trehalose) can be 
important components, while polysaccharides are the main cell wall components. The glucans 
(mainly β-glucans) have not only specifi c chemical structures (β(1→3); β(1→4), β(1→6) 
glycosidic linkages) but also their biological importance is extremely high (see later in 
section of medicinal effects of mushrooms).
Chitin molecules are composed of N-acetyl-glucose-amine units, and they are responsible 
for rigidity and shape of fungal cell wall. Chitin levels in fruit bodies of cultivated mushroom 
range between 2 and 8.5 percent of DM (VETTER, 2007).
Biological effects of mushroom polysaccharides (glucans and mainly chitin) on digestive 
enzymes of consumers are in close connection with the problem of dietary fi bres. The chitin 
and the matrix components (α- and ß-D-glucans and mannans) are nonstarch polysaccharides, 
which molecules can be classifi ed as total dietary fi bre fraction (CHEUNG, 2008; 2013). These 
molecules are practically resistant to digestion and absorption in human small intestine and 
have benefi cial effects such as laxation or attenuation of glucose and/or cholesterol in blood. 
The dietary fi bre has two main fractions: the soluble and the insoluble ones. The total dietary 
fi bre values of A. bisporus and P. ostreatus species are signifi cantly different: 23% DM and 
48–51% DM, respectively (DIKEMAN et al., 2005; SYNYTSYA et al., 2008).
Energy content of cultivated mushrooms is generally low; they belong to diet of low 
energy. Values of Table 2 are calculated for 100 g DM, which means practically 1 kg of fresh 
mass. Ingestion of about 100 g fresh mushroom from A. bisporus gives approximately 30–
32.5 kcal energy, for Pleurotus species these values are slightly higher (41–42 kcal), but the 
use of Agrocybe cylindracea and even more of Auricularia auricula means 13–17 and 9–14 
kcal energy (CHEUNG, 2008). The demonstrated low energy content is one of the nutritional 
and health benefi ts of mushrooms.
Flavour and taste components
Majority of these substances can stimulate production of digestive enzymes; uptake and 
utilisation of nutrients can be better. Number of fragrance substances having identifi ed 
chemical structure is more than 150; they have mainly alcoholic character. One of the most 
characteristic fl avour components is the 1-octen-3-ol, the “mushroom alcohol”. Fruit bodies 
of L. edodes belong to mushrooms of very characteristic fragrance, it is determined by a 
specifi c, S-containing molecule: the lenthionine: 1,2,3,5,6-pentathiepane (VETTER, 2010).
The pleasant almond fl avour of Agaricus subrufescens is formed by interactions of 
benzaldehyde, benzoic acid, benzyl alcohol, methyl benzoate, and 4-hydroxi-benzaldehyde 
(STIJVE et al., 2002).
Vitamins
In general, vitamin B type contents (mainly B3) are higher, between 300 and 650 
mg kg–1 DM; in addition, the levels of folates range between 3000 and 6400 μg kg–1 DM 
(LELLEY & VETTER, 2005). Biological and medicinal importance of vitamin D3 nowadays is 
very high, but our cultivated mushrooms have very low (in some cases not detectable) levels. 
It was shown that UV-B irradiation of cultivated mushrooms (mainly of A. bisporus) can 
produce considerable concentrations of vitamin D2: ergosterol molecules are transformed in 
D2. Most studies have shown signifi cant amount of vitamin D content in UV irradiated 
mushrooms for Agaricus, Pleurotus species and Lentinula edodes, too (see review of TAOFIQ 
and co-workers, 2017).
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Fruiting bodies of cultivated mushrooms contain different quantities of vitamin C 170–
200 mg kg–1 DM (BERNAS et al., 2006). Calculating for daily ingestion of fresh matter (100 g 
fresh mushroom/capita): the possible daily uptake of vitamin C by mushroom is about only 2 
mg.
3. Medicinal values of cultivated mushrooms
3.1. Anticarcinogenic substances and effects
Cell wall of all basidiomycetous mushrooms has certain polysaccharides, as β-glucans and 
chitins. Individual chains of these are linked; covalent bonds are formed between two 
polysaccharides. Quantity of the β-glucane fraction varies between 22 and 52 mg/100 g DM 
(MANZI & PIZZOFERRATO, 2000; see Table 3). The glucanes have water-soluble and water-
insoluble sub-fractions: lower part (18–46%) belongs to water soluble, the higher one (53–
83%) to insoluble fraction. Lentinan (ß-glucan from L. edodes) is a (1→3)-ß-D-glucan 
having two (1→6) glucopyranoside branches for every fi ve (1→3)-ß-glucopyranoside linear 
linkage.
Table 3. ß-Glucan contents and percentages of water-soluble and water-insoluble fractions in Lentinula edodes 
and in different Pleurotus species
Mushroom ß-Glucan content 
(g/100 g DM)
Water-soluble ß-glucan
(%)
Water-insoluble ß-glucan
(%)
Lentinula edodes 0.22 46.1 53.9
Pleurotus ostreatus 0.38 37.8 62.2
P. eryngii 0.38 16.8 83.2
P. pulmonarius 0.53 18.7 81.3
Based on MANZI & PIZZOFERRATO (2000)
Anti-cancer effect of L. edodes (of ß-glucan lentinan) was fi rstly reported by CHIHARA 
and co-workers (1970). Sarcoma 180 cancer cells were transplanted in CD-1/ICD mice and 
lentinan has been shown to inhibit the growth of cancer cells. The preoperative treatment by 
lentinan can cause signifi cant reduction of lung metastasis colony numbers in humans (see 
review of ZHANG and co-workers, 2011). The combination of pre- and post-operative therapy 
with lentinan may be effective to prevent cancer recurrence and metastasis after surgical 
treatments. The main factor of its anti-cancer action is the immuno-stimulating activity 
against cancer (without or in combination with chemotherapy). Lentinan is probable a host 
defence potentiator, which may restore or increase the sensitivity of host cells to different 
molecules as to interleukins, hormones, etc. Lentinan can promote host resistance of the cells 
against different cancer forms, as well as different types of natural killer cells. Stimulation 
seems to be probable for T-cell-, B-cell-, and macrophage-dependent immune system 
responses, too (WASSER & WEISS, 1999). Antitumor effect of lentinan was signifi cantly 
stronger than of other polysaccharides of fungal or plant origin. Lentinan was administered 
to Chinese patients orally or intravenously (ZHANG et al., 2011).
A treatment by Pleurotus ostreatus powder could be a possible therapy in colon 
carcinogenesis (suppression of enzyme activities was demonstrated in mice). Pleuran is a 
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ß-glucan type, having signifi cant anticarcinogenic and immunostimulant effects. P. eryngii 
can produce different ß,1→3 glucans, too, with immune-modulating and antitumor activities 
(STAJIC et al., 2009).
Compounds of almond mushroom (Agaricus subrufescens) with anti-cancer effect were 
fi rst extracted by KAWAGISHI and co-workers (1989). The anti-cancer activity of polysaccharides 
(mainly of ß-glucans) was verifi ed by numerous researchers (LISIECKA et al., 2013), and it was 
shown that the productions of interferon and interleukins are stimulated. Agaricus bisporus 
is a potential breast cancer chemopreventive agent by suppression of aromatase activity and 
oestrogen biosynthesis (CHEN et al., 2006). Its main active compounds are unsaturated fatty 
acids as linoleic acid, linolenic acid, and conjugated linoleic acid, which can bind to the 
active site of aromatase enzyme (as non-competitive inhibitors).
Ganoderma lucidum sensu lato (reishi) fruiting bodies possess anticarcinogenic 
substances as triterpenes and some glucan molecules (KAO et al., 2013). Such triterpenes are: 
ganoderic acid T, D and ganoderiol F. G. lucidum extract can end the cell cycle at the G1 
phase (JEDINAK et al., 2011), by a down regulation of cyclin D1 molecules (latter are essential 
regulators for G1/S transition in the cell cycle). Induction of apoptosis was detected by 
triterpenes of reishi. Other essential effect of reishi triterpenes is the reduction of cancer 
metastasis (by regulation of some key proteins). Ganoderic acid for example can inhibit the 
activity of matrix metalloproteinase protein family responsible for promotion of metastasis.
Mode of the anti-cancer action of β-D-glucans isolated from G. lucidum seems to have 
three main mechanisms:
a) Improved immune responses (the stimulation of macrophages, natural killer (NK) 
cells, and cytotoxic T lymphocytes); b) Higher anti-oxidative activity (which can reduce the 
oxidative damage); c) Inhibition of angiogenesis.
Limited clinical studies (case reports, randomized controlled trials) suggest reishi as an 
alternative adjunct therapy for improvement of immune system of cancer patients (CHENG & 
SLIVA, 2015).
3.2. Antidiabetic substances and effects
Development of diabetes is controlled by multiple inherited and environmental factors (DE 
SILVA et al., 2012). Type 1 diabetes occurs due to inherited factors, but type 2 diabetes is due 
mainly to environmental factors (including nutritional ones). A signifi cant anti-glycaemic 
effect was produced by white button mushroom (A. bisporus) fruiting bodies ingested by 
diabetic rats (JEONG et al., 2010). This is probably a multicomponent effect, originating from 
different constituents including dietary fi bres, some anti-oxidants, proteins, and 
polysaccharides. The β-glucan fraction can reduce blood glucose level, and can improve the 
pancreatic β-cells: by inhibition of α-glucosidase activity and by stimulation of insulin 
production (HIGAKI et al., 2005).
Pleurotus ostreatus extracts (especially in higher concentrations) reduced blood glucose 
level in hyperglycaemic rats (GHALY et al., 2011). A signifi cant correlation was found between 
mushroom supplementation and reduction of high blood sugar content for 120 diabetic 
patients of type 2 (AGRAWAL et al., 2010).
An exopolymer produced by submerged mycelia culture of shiitake decreased plasma 
glucose level by 21.5% and increased insulin level by 22% in diabetic rats (YANG et al., 
2002). The “effective” molecule is a glycoprotein (molecular mass 52 000, protein content 
16.5%, carbohydrate content 83.5%).
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Fruiting bodies of Coprinus comatus (ink cap mushroom) have one anti-diabetic 
molecule, the comatin (4,5-dihydroxi-2-methoxy-benzaldehyde). It is an inhibitor for non-
enzymatic glycosylation. Blood glucose content of rats (treated with comatin at 80 mg kg–1 
bw.) was reduced from 5.14 mM to 4.28 mM in 3 h (DING et al., 2010). Glucose lowering 
activity of G. lucidum polysaccharides is related to facilitation of Ca2+ infl ux into ß-cells of 
pancreas and thus to insulin release. A reversion of viability of pancreatic islets was found in 
animal model experiments (ZHANG et al., 2003). Ingestion of Ganoderma polysaccharides is 
benefi cial for therapy of diabetes type 2; they can decrease the serum glucose level via hepatic 
phosphoenolpyruvate carboxykinase. This suppression can cause a decrease (lowering) in 
gluconeogenesis (SETO et al., 2009). In a randomized, placebo-controlled clinical study, the 
ganopoly (an extracted polysaccharide fraction of mushroom) was given to 71 patients of 
diabetes type 2 and a blood glucose lowering was demonstrated (GAO et al., 2004).
Antidiabetic effect of Auricularia auricula-judae (=Hirneola auricula-judae) was 
demonstrated in diabetic mice; ingestion of mushroom had a lowering effect in plasma 
glucose, in total cholesterol, and in triglyceride levels (KIM et al., 2007). The maitake 
mushroom (Grifola frondosa) can lower blood sugar level by its α-glucosidase inhibitors 
(HONG et al., 2007).
3.3. Antimicrobial substances and effects
Mushrooms need different antimicrobial compounds to survive and reproduce in natural 
environment. An alcoholic extract of white button mushroom was tested in vitro, and it had 
strongly inhibited the growth of some Gram-positive bacteria (Bacillus subtilis, Staphylococcus 
aureus, and Pseudomonas aeruginosa (JAGADISH et al., 2009). Extracts of fresh or dehydrated 
fruiting bodies of mycelium of P. ostreatus inhibited the growth of Bacillus subtilis and 
Escherichia coli (KHAN & TANIA, 2012).
Certain triterpenes of Ganoderma lucidum sensu lato, as ganoderol F, ganodermanontriol, 
and ganoderic acid B, have direct antiviral effects against HIV-1. Lentinan has shown antiviral 
activity in animal experiments (against vesicular stomatitis virus, encephalitis virus, Abelson 
virus, and adenovirus type 12). The mode of action of its antiviral effects is indirect; the 
immune system is stimulated.
Some Pleurotus species have shown certain antiviral effects. A laccase enzyme was 
isolated and purifi ed from P. ostreatus fruiting bodies inhibiting the entry and replication of 
hepatitis C virus. Other laccase variant from P. cornucopiae can decrease the activity of HIV-1 
reverse transcriptase (see review of KHAN and TANIA, 2012).
3.4. Antioxidant substances and effects
Antioxidant capacity of mushrooms can be characterized approximately by contents of 
phenolics or there are different methods for estimation of the actual “capacity” of this system 
(measurement of reducing power, of inhibition of lipid peroxidation, evaluation of scavenging 
activity for free radicals, etc.).
Total phenolic content of certain cultivated mushroom fruiting bodies are demonstrated 
in Table 4 (WANG & XU, 2014). Phenolic compounds may provide antioxidative character via 
different ways, such as decomposing primary products of oxidation, intercepting singlet 
oxygen, etc. The antioxidant property of Coprinus comatus fruiting bodies is provided by 
their naturally occurring components as ascorbic acid (0.04–2.95 mg g–1), total tocopherol 
content (0–4.94 mg g–1), and total phenolics (2.3–7.3 mg g–1) (TSAI et al., 2009). Study of SUN 
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and co-workers (2004) revealed that the peptide fraction is the major antioxidant of G. 
lucidum sensu lato.
Table 4. Total phenolic contents and free radical scavenging activity of some cultivated mushrooms
Mushroom Total phenolics 
from water extract
(1)
(mg GAE/g DM)
Total phenolics 
from hot water 
extract (2)
(mg GAE/g DM)
DPPH free radical 
scavenging activity
(1)
(μmol TE/g DM)
DPPH free radical 
scavenging activity
(2)
(μmol TE/g DM)
Agaricus subrufescens 2.82 1.01 4.94 3.76
Pleurotus eryngii 3.65 1.52 3.72 4.45
Lentinula edodes 4.26 1.82 1.40 2.93
Auricularia auricula 0.82 0.35 2.42 2.18
Agrocybe cylindracea 5.71 2.99 3.32 4.64
Grifola frondosa 3.78 2.34 1.75 2.47
Pholiota nameko 7.31 2.15 2.13 3.99
Based on data of WANG & XU (2014)
GAE: gallic acid equivalent; TE: Trolox equivalent; DPPH: α,α-diphenyl-β-picrylhydrazyl
4. Conclusions
Chemical composition (occurrence, quantity, and rates of certain constituents) determines the 
biological value of our cultivated mushrooms. Main biological values of mushrooms are 
specifi ed as follows:
• Mineral composition of fruiting bodies differs completely from other living groups. 
Four mineral elements give 97–98% of total quantity; K and P have the highest amounts, 
supplemented with a very low sodium level. Occurrence of selenium (mainly in Agaricus 
species and varieties) can be benefi cial for its biological effects.
• Concentration of the favourable protein molecules fl uctuates between 25 and 35% for 
DM. Metabolism and utilisation of these proteins are basically determined by the 
benefi cial rate of essential amino acids and by occurrence of proteins from albumin-
globulin groups (81.6% for P. eryngii and 66% for P. ostreatus). Crude fat content is low 
(0.5–5.4% DM), having a role in low energy values of mushrooms. Crude carbohydrate 
content ranges between 50 and 85% of DM. Compounds of dietary fi bre group (insoluble 
polysaccharides including some glucans and chitin) give a substantial rate of total 
carbohydrates. Their biological effect is benefi cial for digestion; anti-cancer effects of 
certain glucans (mainly of ß-glucans) nowadays become more and more important.
• Substances responsible for taste and fragrance of mushrooms can stimulate digestion 
and absorption of nutrients.
• Dynamic increase of cultivation of certain mushrooms (as A. subrufescens, Pleurotus 
eryngii, Grifola frondosa, or Ganoderma lucidum sensu lato) is interpretable by 
existence of medicinal compounds. The anti-cancer (anticarcinogenic) effects of these 
mushrooms have outstanding importance. These effects are mainly connected to 
ß-glucans (for example: lentinan from L. edodes) and to certain triterpene derivatives 
(ganoderic acid T, D) or to some unsaturated fatty acids (linoleic acid, linolenic acid). 
These ingredients mostly activate different components of the immune system. 
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Medicinal use of these substances is possible in therapy or in prevention, alone or in 
combination.
• Certain cultivated mushrooms (A. bisporus, P. ostreatus, Coprinus comatus, and 
Ganoderma lucidum sensu lato) have antidiabetic effects, which can improve the 
glucose metabolism mainly for patients of diabetes type 2. Extracts of many cultivated 
mushrooms have antimicrobial effects against Gram-negative and Gram-positive 
bacteria and certain viruses (HIV-1, hepatitis C, vesicular stomatitis virus, encephalitis 
virus).
• The published scientifi c data justify occurrence of different substances with antioxidative 
character (phenolics, polysaccharides, etc.). Synergistic effect of these molecules may 
stimulate the free radical scavenging activity of these mushrooms.
According to an old Chinese proverb: “Medicine and food have a common origin”. 
Cultivated mushrooms are excellent examples of this duality.
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